Coherus Oncology, Inc.
UnclaimedPharmaceutical Preparation ManufacturingRedwood City, CA
Founded
2010
Primary NAICS
325412
CAGE code
88J79
Federal awards
$11.8M
Overview
Coherus Oncology is a commercial-stage company advancing next-generation combination therapies to elevate what’s possible for people living with cancer.
Classification
This U.S. industry comprises establishments primarily engaged in manufacturing in-vivo diagnostic substances and pharmaceutical preparations (except biological) intended for internal and external consumption in dose forms, such as ampoules, tablets, capsules, vials, ointments, powders, solutions, and suspensions.
- Manufacturing32
- Chemical Manufacturing325
- Pharmaceutical and Medicine Manufacturing32541
- Pharmaceutical Preparation Manufacturing325412
Capabilities
Drugs and Biologicals
Federal awards
| Year | Agency | Obligated | Actions |
|---|---|---|---|
| 2026 | Department of Health and Human Services | $0 | 1 |
| 2026 | Department of Veterans Affairs | $0 | 7 |
| 2025 | Department of Health and Human Services | $11,805,200 | 1 |
| 2025 | Department of Veterans Affairs | $0 | 4 |
| 2024 | Department of Veterans Affairs | $0 | 11 |
| 2023 | Department of Veterans Affairs | $0 | 10 |
| 2022 | Department of Veterans Affairs | $0 | 2 |